Press Releases for AZN

Press Releases
Softscape and Jobfox Deliver New Breakthrough Innovation for E-Recruitment
Phase Forward Reports Third Quarter 2009 Results
Howard Dean to Speak at the 2009 Mid-Atlantic Bio Conference
AstraZeneca: Third Quarter and Nine Months Results 2009
POZEN Reports Third Quarter 2009 Results
Bristol-Myers Squibb Achieves Strong Sales, Earnings Performance in Third Quarter
Merck Announces Third-Quarter 2009 Financial Results
Drug makers, CVS slammed for promos
Cubist Pharmaceuticals 3rd Quarter Total Net Revenues Up 28%
Targacept Announces Pricing of Common Stock Offering
Targacept Announces Common Stock Offering
Troux Secures $10 Million to Extend Growth in New Geographies and Channels
Bank of Georgia Selects Softscape for Complete Talent Management Solution
Teva Provides Update on Generic Seroquel® Litigation
M-Files 6.0 Document Management Software Delivers Powerful New Features With Unprecedented Ease of Use
Symyx Joins SAFE-BioPharma to Ensure Safe Security Standards for ELN Software; Pharmaceutical Industry Non-Profit Maintains Standards and Certification for Digital Signatures
POZEN Names Elizabeth A. Cermak As Executive Vice President, Chief Commercial Officer
Fitch: Credit Quality Stable for Global Pharma Sector With Increase of New Drug Approvals in 2Q'09
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2009 Results; Teleconference and Webcast to Be Held on September 8, 2009
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2009 Results; Teleconference and Webcast to Be Held on September 8, 2009
Video: AstraZeneca Traveling Exhibit Helps Americans Understand and Manage Bipolar Depression
'Don't Play With the Flu'(TM) Campaign to Coach Families on Playing Defense Against Seasonal Flu
U.S. volunteers sign up for vaccine tests
China Pharma Holdings, Inc. Announces SFDA Approval for Production of Omeprazole Injections ; Broadens Product Offerings for Multiple Therapeutic Markets
Softscape Continues Record Breaking Growth Winning Numerous Global 2000 Accounts for Large HR Platform Deployments
MedImmune Advances Three Oncology Programs Into the Clinic
BioMed Realty Trust Commemorates Five-Year Anniversary As a Public Company ; Ringing NYSE Closing Bell(R) Today; Provides Tenant Update
Par Pharmaceutical Reports EPS of $0.71 for Second Quarter 2009
StockPreacher.com Issues Trading Outlook for ViroPharma Inc.
Project Zero Delay Accelerates Drug's Path to Clinical Trial
MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results
U.S. Food and Drug Administration Approves ONGLYZA™ (saxagliptin) for the Treatment of Type 2 Diabetes Mellitus in Adults
AstraZeneca and the Artery Explorer Take California Residents on Virtual Journey Through the Arteries
Nasal vaccine developed for swine flu
AstraZeneca Submits New Drug Applications for ZACTIMA(TM) in Second-Line Advanced Non-Small Cell Lung Cancer
AstraZeneca: Second Quarter and Half Year Results 2009
POZEN Reports Second Quarter 2009 Results
FluMist(R) Begins Shipping for 2009-2010 Influenza Season
Phase Forward Reports Second Quarter 2009 Results
/C O R R E C T I O N -- Digitas Health /
Digitas Health Expands Adding Two Key Locations
AstraZeneca Expands Prescription Savings Program
Alcon Reports Solid Financial Results for Second Quarter
Merck Announces Second-Quarter 2009 Financial Results
AstraZeneca Partners With Primary Health Care to Help Iowa Uninsured
AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimer's Disease
StreetInvesting.Com Free Research on FE, HLS, SUG, TM, WAB and AZN
New Five-Question Test Helps Assess Asthma Control in Children Under Five Years of Age
Phase Forward Celebrates Five Years on NASDAQ
Linguamatics Extends License to Its Agile Text Mining Platform for AstraZeneca
Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Casodex(R) Tablets
Softscape Rated the Top Supplier of Total Compensation Management According To Ventana Research
Catalyst Biosciences Announces Agreement With MedImmune to Discover and Develop Engineered Protease Therapeutics
New Report Just Published: World Content Management Software Market Report
MattsonJack Adds Indications to Epi Database
Crestor Patent Invalidity Evidence Uncovered By Article One Partners Community
New Expanded Atlantis™ Patient-Specific Abutment Compatibility and Material Option for Straumann Implants
MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants
MedImmune Expands Access for Eligible Premature Infants to Receive Synagis(R) at No Cost
ONGLYZA™ (Saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes
EquipNet Celebrates a Decade in Business With Launch of New Website
SAFE-BioPharma Changes Fees to Help Clinical Investigators, CROs, Others
June 23 DIA Sessions Chaired By SAFE-BioPharma Association
Philadelphia Cancer Patients to Benefit from Expansion of the American Cancer Society Patient Navigator Program
Reportlinker Adds R&D Cost Cutting: Managing Cost Containment and Safeguarding Productivity
Favorable Vote From FDA Advisory Committee on SEROQUEL Pediatric Supplemental New Drug Applications
Interim Analysis of Long-Term Data with ONGLYZA™ (saxagliptin) When Added to Metformin in People with Inadequately Controlled Type 2 Diabetes Presented at ADA Annual Scientific Sessions
Dapagliflozin Study Demonstrated Improved Glycemic Control In Type 2 Diabetes Patients Treated With High Doses of Insulin and Common Oral Anti-Diabetic Medicines
AstraZeneca Studies Show Relief of Nighttime Heartburn and Reduction in GERD-Related Sleep Disturbances
HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A (H1N1)
AstraZeneca and Merck & Co., Inc. Form Pioneering Collaboration to Investigate Novel Combination Anticancer Regimen
Iressa beneficial as gene-targeting drug
Marketwire to Be Official Newswire of ExL Pharma's 5th PR &Amp; Communications Summit
Photo: MultiVu Appoints Missy Gartner to Spearhead Business Development and Customer Integration for New Multimedia Asset Management and Distribution Platform
MaybachFinancial.Com Posts Free Analyst Report on ANF, TTM, AMD and AZN
AstraZeneca, the National Alliance for Hispanic Health and LULAC Join Forces to Promote Needed Heart Health Education in Hispanic Communities
AstraZeneca Announces TOPROL-XL(R) (Metoprolol Succinate) is Now Available
Palatin Technologies, Inc. Reports Fiscal Year 2009 Third Quarter Results; Teleconference and Webcast to Be Held on May 15, 2009
POZEN Receives Decision From AstraZeneca to File PN 400 NDA
Targacept Reports First Quarter 2009 Financial Results
MattsonJack to Present at Access to Innovative Cancer Therapies in 2009 - 4th Annual Oncology Economics Forum
Phase Forward to Host Seventh Annual European Users Conference
Broad Street Ventures Acquires 950 Wind River Lane, Adds MedImmune to List of Tenants
Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009
MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants
POZEN Reports First Quarter 2009 Results
UPI NewsTrack Business - Apr 29 2009 6:54PM
Phase Forward Reports First Quarter 2009 Results
Bristol-Myers Squibb Reports Excellent First Quarter Financial Results; Delivers on Two Significant Strategic Initiatives
StepStone ASA:Strong Operating Performance in Q1 Despite Challenging Economic Conditions - 16% EBITDA Margin and â‚¬4.6m Cash From Operations in Q1 2009
MattsonJack Hires Gary Sullivan, Augments Business Development Expertise
Troux Announces Record Q1 Growth, Extends Leadership in Strategic IT Planning Software
Cubist Pharmaceuticals 1Q09 Total Net Revenues Up 37%; Total Net Revenues $121.1 Million; Net Product Revenues $114.6 Million
Merck Announces First-Quarter 2009 Financial Results
FDA Advisory Committee Recommendation on SEROQUEL XR Supplemental New Drug Applications
SAS Launches Physician Targeting Solution
Astra Tech Reduces Turnaround Time for Atlantis™ Patient-Specific Abutments
MattsonJack to Lead Workshop at Pharmaceutical Strategic Outlook and BIO-Windhover
FDA Advisory Committee Documents for SEROQUEL XR Available on AstraZeneca Web Site
AstraZeneca's David Brennan Elected PhRMA Board Chairman